Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.
Authors: Aaron Iding, Ruben Hupperetz, Rutger Brans, Hugo Ten cate, Daan van Twist, Arina J. Ten Cate-Hoek”
Read the full article here.
Article: Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Authors: Aaron Iding, Ruben D. Hupperetz, Rutger J. B. Brans, Hugo ten Cate, Daan J. L. van Twist, Arina J. ten Cate-Hoek
Stay updated on all scientific advances with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk